Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M
by
Contributor since / Followers
Contributor since / Followers
2 months ago
- Acadia Pharma press release (NASDAQ:ACAD): Q3 GAAP EPS of $0.20 beats by $0.06.
- Revenue of $250.4M (+18.3% Y/Y) beats by $1.56M.